The problem in one sentence
An athlete enters an altitude block with ferritin at the low end of normal, completes the prescribed hypoxic dose, and leaves with a hemoglobin mass that has barely moved. The usual explanation is that the athlete is a “non-responder.” That label is doing less work than it appears to. The more useful question is whether the iron supply was ever sufficient for the erythropoietic signal to be converted into new red cell mass, and whether the daily training schedule was quietly closing the absorption window that the altitude exposure had opened.
This article separates what the literature actually documents from what coaches reasonably infer. The distinction matters, because the practical recommendations that follow are partly extrapolation. I will flag where the evidence stops.
Hepcidin is the lever, and it is a single lever
Hepcidin is a liver-derived peptide hormone that binds the cellular iron exporter ferroportin, causing its internalization and degradation. The consequence is reduced export of iron from enterocytes, macrophages, and hepatocytes into plasma. In the gut, that means less dietary iron reaches circulation; in the reticuloendothelial system, it means less recycled iron from senescent red cells is returned to the marrow (Nemeth et al., 2004, as summarized in Domínguez et al., 2018).
This is why hepcidin is the right place to look when altitude adaptation stalls. Erythropoiesis is an iron-intensive process, and the marrow can only build hemoglobin from iron that reaches it. If hepcidin is high, the iron is there but locked in cells. If hepcidin is low, absorption and recycling both improve.
Two signals push hepcidin in opposite directions in an altitude camp, and they operate on different timescales. That is the core of the argument.
Signal one: hypoxia lowers resting hepcidin
Płoszczyca and colleagues (2023) studied twenty trained male cyclists during a three-week live-high-train-low protocol: 11–12 hours per day of normobaric hypoxia at FiO₂ 16.5 percent (roughly 2000 m), with training performed in normoxia. In the hypoxic group, resting hepcidin fell by 13.0 percent immediately after the intervention and remained reduced three days later. Erythroferrone, the erythroblast-derived hormone often proposed as the hepcidin suppressor during erythropoiesis, fell by 28.7 percent and returned to baseline by day three. The authors found no association between hepcidin and erythroferrone after the intervention and concluded that erythroferrone is probably not the only factor suppressing hepcidin under moderate hypoxia, particularly in the later stages.
That last point deserves emphasis because it is frequently misstated in coaching circles. The erythroferrone-to-hepcidin pathway is real and well described in the hematology literature, but this study did not find it operating as the dominant regulator in a three-week moderate-altitude block. The authors also noted that with the cessation of hypoxia, the favorable conditions for increasing iron availability cease. In other words, the suppression is contingent on continued exposure.
The same study is a useful corrective to a second assumption. The control group, training normally at sea level, saw hepcidin rise by 73.9 percent over the three weeks. Ordinary training load, without hypoxia, drives hepcidin up. This is the background against which any altitude camp is superimposed.
Signal two: a single hard session raises hepcidin for hours
Domínguez and colleagues (2018) systematically reviewed nineteen studies of acute exercise and serum hepcidin. Their synthesis: a single endurance session, continuous or interval, at 60–90 percent of VO₂peak raises circulating hepcidin between zero and six hours after exercise, peaking around three hours. The magnitude appears to depend on pre-exercise ferritin and on the inflammatory response, particularly interleukin-6.
Two caveats belong here. First, the review itself frames the early post-exercise rise cautiously in places, and the underlying studies vary in assay, timing, and population. Second, the practical implication is not a precise clock. A zero-to-six-hour window with a three-hour mode is a planning constraint, not a prescription. Anyone who tells you to supplement at exactly hour three is extrapolating past the data.
What the review does establish is directional and useful: after a hard endurance session, the gut is a less effective place to absorb iron than it was before the session, and it stays that way for a good part of the recovery period.
The two clocks, and why they do not simply cancel
Put the two signals side by side. Over a three-week block, chronic hypoxic exposure lowers resting hepcidin. Over a three-to-six-hour window after each hard session, exercise raises it. These are not competing explanations; they are different timescales operating on the same variable.
The unresolved question is which signal dominates on any given day. The retrieved sources do not answer it. No study in this set measured hepcidin repeatedly across a full training day during an altitude camp, with iron absorption as an outcome. The reasonable inference, and I want to label it as inference, is that the post-exercise elevation temporarily overrides the chronic hypoxic suppression, and that the duration and magnitude of that override depend on the session and on the athlete’s iron status.
This is where the low-ferritin athlete gets into trouble. If pre-exercise ferritin is low, the hepcidin response to exercise appears to be modulated, and the athlete has less stored iron to draw on during the windows when absorption is favorable. The altitude block generates an erythropoietic signal; the iron supply to service that signal is intermittent at best.
What the evidence does not support
Several claims circulate widely and are not established by the sources reviewed here.
That altitude responders specifically fail because of low ferritin. The literature describes iron-dependent blunting of the hematological response to hypoxia in general terms. It does not define a responder phenotype by ferritin threshold, and the studies that stratify by ferritin are not in this evidence set. The framing in the title of this article is a hypothesis with mechanistic plausibility, not a documented classification.
That a specific supplementation schedule fixes the problem. No trial in this set tested iron timing relative to training during an altitude camp with ferritin or hemoglobin mass as outcomes. Any specific protocol, whether “take iron in the morning” or “avoid iron for four hours post-session,” is extrapolation from the absorption physiology, not a tested intervention.
That the post-hypoxia window produces measurable erythropoietic benefit. The Płoszczyca study measured hormones, not hemoglobin mass or performance. The finding that hepcidin remains suppressed three days after hypoxia ends is interesting and testable. It is not evidence that the recovery week should be used as an iron-loading window, though that is a reasonable hypothesis.
That erythroferrone explains hypoxic hepcidin suppression. The study that measured both found no association after the intervention. The pathway exists; it was not the operative one in this protocol.
A practical framework, clearly labeled as reasoning
The following is my synthesis of the mechanisms above, not a validated protocol. It is offered because coaches need a decision structure, and because the alternative, treating every altitude camp as identical, is worse.
Screen ferritin before the camp, not after
If the hematological response depends on iron availability, then ferritin status at entry is the variable most likely to determine whether the camp produces anything. This is a higher-yield intervention than adjusting the hypoxic dose, because the retrieved evidence ties non-response to iron sufficiency rather than to the specifics of the altitude protocol. The Płoszczyca protocol used 250 hours at 2000–2500 m, which the authors cite as previously effective; the failure mode in the literature is not usually an inadequate dose, it is an inadequate substrate.
What ferritin threshold to use is a clinical question, not a coaching one. The sources here do not establish a cutoff. That decision belongs with the athlete’s physician, informed by the full iron panel and the training context.
Treat the post-exercise window as a planning constraint
If hepcidin peaks around three hours post-exercise and stays elevated for up to six, then the hours immediately after a hard session are the least efficient time to deliver oral iron. The practical move is to place iron intake in a window that is temporally distant from the hardest sessions, typically earlier in the day or on days with lighter training. This is reasoning from absorption physiology, not a tested schedule.
The corollary is that the athlete who takes iron with breakfast and then does a four-hour ride at noon has probably absorbed the iron before the session raised hepcidin. The athlete who takes iron immediately after the ride has probably not. That distinction is worth more than most supplement-selection debates.
Do not assume the camp is a single iron state
The chronic hypoxic suppression and the acute exercise elevation mean that an altitude camp is not one iron environment. It is a repeating cycle: overnight hypoxia lowers hepcidin, the morning session raises it, the afternoon is a partial recovery, the evening exposure lowers it again. Planning iron around that cycle is more sensible than planning it around the camp as a whole.
Consider the post-camp week deliberately
Płoszczyca and colleagues found hepcidin still suppressed three days after hypoxia ended. If that suppression reflects genuine absorptive capacity, the early post-camp period may be a favorable window for iron intake. This is a hypothesis. It has not been tested with absorption or hemoglobin mass outcomes. But it is a testable one, and it is more biologically grounded than treating the camp as ending the moment the athlete leaves altitude.
What would change this advice
Three pieces of evidence would materially revise the framework above.
First, a study stratifying altitude-training hematological response by pre-camp ferritin, with responders and non-responders defined prospectively. That would convert the central hypothesis of this article into a documented relationship or refute it.
Second, a trial testing iron supplementation timing relative to training sessions during an altitude camp, with ferritin and hemoglobin mass as outcomes. That would replace the extrapolated timing advice with an tested protocol.
Third, data on whether the post-hypoxia hepcidin suppression window produces measurable increases in iron absorption or erythropoiesis in athletes. That would determine whether the post-camp week deserves deliberate management or is simply a return to baseline.
Until then, the honest position is this: the mechanism connecting hepcidin, exercise, hypoxia, and iron absorption is well described; the practical timing rules that follow from it are reasoned, not proven; and the low-ferritin athlete entering an altitude camp is a plausible failure mode with a coherent physiological explanation, not a documented clinical category.
FAQ
Does a hard session really block iron absorption for six hours?
The review by Domínguez and colleagues reports hepcidin elevation from zero to six hours post-exercise, peaking around three. Hepcidin reduces ferroportin-mediated iron export, which is the mechanism by which absorption falls. The six-hour figure is the outer bound of the observed hepcidin response, not a measured absorption blockade. Individual variation is substantial.
Should I take iron during an altitude camp at all?
That is a clinical decision, and the sources here do not establish a dose or a schedule. What the evidence supports is that iron availability is a limiting factor for the hematological response to hypoxia, and that the post-exercise window is a less efficient time to deliver oral iron. Whether to supplement, and how much, belongs with the athlete’s physician.
Why did my athlete’s hemoglobin mass not rise after a camp that worked for teammates?
The most likely explanation in the literature is insufficient iron availability, but the sources here do not establish a ferritin threshold or a responder classification. Other variables, including the hypoxic dose, the training load during the camp, and individual variation in the erythropoietic response, are also plausible. Ferritin status is the first thing to check, not the only thing.
Does erythroferrone explain why hepcidin falls at altitude?
Not in the study that measured both. Płoszczyca and colleagues found no association between hepcidin and erythroferrone after a three-week live-high-train-low protocol, and concluded that erythroferrone is probably not the only suppressor under moderate hypoxia. The pathway is real; it was not the dominant one in that protocol.
Is the post-camp week a good time to load iron?
It is a reasonable hypothesis. Hepcidin remained suppressed three days after hypoxia ended in the Płoszczyca study, which would be consistent with improved absorptive capacity. But that study measured hormones, not absorption or hemoglobin mass, so the practical recommendation is inference, not established fact.